Chromatin modifications by the methyltransferase SETD7 modulate angiogenic response in diabetes: Insights for epigenetic-based therapies. (December 2020) - Mohammed, S.A.; Costantino, S.; Akhmedov, A.; Karsay, G.; Ambrosini, S.; Madeddu, P.; Spinetti, G.; Lüscher, T.F.; Paneni, F.